Last searches
Results for *
Displaying results 1 to 25 of 77.
-
Politik-Check Pharmastandort Deutschland - Potenziale erkennen, Chancen nutzen
-
Costly information in firm transformation, exit, or persistent failure
-
To America's health
a proposal to reform the Food and Drug Administration -
Tono-Bungay
-
Murder in Havana
-
Gombo
-
Tono-Bungay
-
The Chemical and Pharmaceutical Industry in China
Opportunities and Threats for Foreign Companies -
Whiteout
-
How health care reform affects pharmaceutical research and development
-
India-Africa healthcare cooperation
way forward -
Medioambiente en la Argentina
prioridades y regulaciones ; un estudio de casos -
The Indian pharmaceutical sector
issues and options for health sector reform -
Drug industry in the Philippines
-
The impact of price regulation on the launch delay of new drugs
evidence from twenty-five major markets in the 1990s -
The impact of new drug launches on longevity
evidence from longitudinal, disease-level data from 52 countries, 1982 - 2001 -
Market size in innovation
theory and evidence from the pharmaceutical industry -
IP & external consumption effects
generalizations from health care markets -
Making markets for vaccines
ideas to action ; the report of the Center for Global Development, Advance Market Commitment Working Group. Ruth Levine, Michael Kremer, Alice Albright, co-chairs. [Lead report authors Owen Barder ...] -
Acquiring knowledge within and across firm boundaries
evidence from clinical development -
To America's health
a proposal to reform the Food and Drug Administration -
Competition between generic and brand name drugs
new evidence from the U.S. pharmaceutical market -
Globalisation and its impact on competitiveness
the case of the British and German pharmaceutical industry -
Mergers and acquisitions in the pharmaceutical and biotech industries
-
Powerful medicines
the benefits, risks, and costs of prescription drugs